XML 90 R79.htm IDEA: XBRL DOCUMENT v3.10.0.1
Capital Stock (Stock Option, Restricted Stock and Restricted Share Unit Activity) (Details)
9 Months Ended
Dec. 31, 2018
$ / shares
shares
Class A Voting Shares | Stock Options and Equity-Settled SARs  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Outstanding at March 31, 2018 (in shares) | shares 8,636,437
Granted (in shares) | shares 155,705
Options exercised (in shares) | shares (25,657)
Forfeited or expired (in shares) | shares (392,788)
Outstanding at December 31, 2018 (in shares) | shares 8,373,697
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]  
Outstanding at March 31, 2018, weighted average exercise price (in usd per share) | $ / shares $ 26.93
Granted, weighted average exercise price (in usd per share) | $ / shares 28.07
Options exercised, weighted average exercise price (in usd per share) | $ / shares 21.74
Forfeited or expired, weighted average exercise price (in usd per share) | $ / shares 33.49
Outstanding at September 30, 2018, weighted average exercise price (in usd per share) | $ / shares $ 26.66
Class A Voting Shares | Restricted Stock and Restricted Share Units (RSUs)  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Outstanding at March 31, 2018 (in shares) | shares 230,561
Granted (in shares) | shares 30,001
Restricted stock or RSUs vested (in shares) | shares (133,560)
Forfeited or expired (in shares) | shares (12,767)
Outstanding at December 31, 2018 (in shares) | shares 114,235
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Outstanding at March 31, 2018, weighted average grant-date fair value (in usd per share) | $ / shares $ 28.49
Granted, weighted average grant date fair value (in usd per share) | $ / shares 23.51
Restricted stock or RSUs vested, weighted average grant-date fair value (in usd per share) | $ / shares 29.56
Forfeited or expired, weighted average grant-date fair value (in usd per share) | $ / shares 25.30
Outstanding at December 31, 2018, weighted average grant-date fair value (in usd per share) | $ / shares $ 26.28
Class B Non-Voting Shares | Stock Options and Equity-Settled SARs  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]  
Outstanding at March 31, 2018 (in shares) | shares 23,463,115
Granted (in shares) | shares 3,190,256
Options exercised (in shares) | shares (277,609)
Forfeited or expired (in shares) | shares (630,510)
Outstanding at December 31, 2018 (in shares) | shares 25,745,252
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]  
Outstanding at March 31, 2018, weighted average exercise price (in usd per share) | $ / shares $ 20.56
Granted, weighted average exercise price (in usd per share) | $ / shares 23.37
Options exercised, weighted average exercise price (in usd per share) | $ / shares 14.97
Forfeited or expired, weighted average exercise price (in usd per share) | $ / shares 30.47
Outstanding at September 30, 2018, weighted average exercise price (in usd per share) | $ / shares $ 20.74
Class B Non-Voting Shares | Restricted Stock and Restricted Share Units (RSUs)  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]  
Outstanding at March 31, 2018 (in shares) | shares 2,001,049
Granted (in shares) | shares 830,972
Restricted stock or RSUs vested (in shares) | shares (649,659)
Forfeited or expired (in shares) | shares (84,597)
Outstanding at December 31, 2018 (in shares) | shares 2,097,765
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]  
Outstanding at March 31, 2018, weighted average grant-date fair value (in usd per share) | $ / shares $ 27.97
Granted, weighted average grant date fair value (in usd per share) | $ / shares 22.05
Restricted stock or RSUs vested, weighted average grant-date fair value (in usd per share) | $ / shares 28.07
Forfeited or expired, weighted average grant-date fair value (in usd per share) | $ / shares 27.07
Outstanding at December 31, 2018, weighted average grant-date fair value (in usd per share) | $ / shares $ 25.63